申请人:Gillead Sciences, Inc.
公开号:US20170065592A1
公开(公告)日:2017-03-09
Provided are modulators of TLRs of Formula II:
pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.